Having spent much of my career reviewing abstinence-only-until-marriage curricula and material, I can promise that just adding a lesson about contraception cannot turn a fear- and shame-based program into anything better.
Despite overwhelming scientific evidence showing that vaccines are safe and effective, many parents have become skeptical. Efforts to encourage these parents to change their minds have most often focused on correcting misinformation. A new study, however, suggests that this approach may backfire.
Despite a mounting body of evidence to the contrary, there continues to be a fear among adults that vaccinating young people against an STD is akin to giving them a license to have sex. Yet another study promises this isn’t going to happen.
This week, Chicago launches a new initiative to up the number of teens who get vaccinated for HPV, a Spanish study makes headlines about how rich people supposedly have better sex, and a New York Times op-ed urges safe sex for seniors.
The Centers for Disease Control and Prevention has released sexually transmitted disease surveillance data for 2012, and the news is not good: Cases of chlamydia, gonorrhea, and syphilis all continued to rise.
Recent political developments suggest some growing political awareness of sex workers as human beings.
It was reported recently that French drug manufacturer HRA Pharma had found that the emergency contraceptive Norlevo, which has a similar chemical makeup to Plan B One-Step, is ineffective for women over 176 pounds. Here’s why I was not surprised.
In his defense of the faceless poor, the pope misses the fact that women are more likely than men to be in poverty—because of the very kind of structural inequality that his church models for the world as an image of holiness.
Last year, Republican senators, led by far-right ideologues Michael Farris and Rick Santorum, defeated ratification of a UN treaty based on the Americans With Disabilities Act. Will they succeed again this year?
A new study of women in Costa Rica finds that one dose of the HPV vaccine may be enough to create the antibodies needed to prevent infection. If confirmed, this could be good news for people in the United States and abroad.